Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Ever U.S. Approval for Cold Machine Perfusion in ...

Bridge to Life™ Ltd., a global innovator in organ preservation and perfusion technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo clearance for the ...
European Medical Journal

Elevated Perfusion Pressure Duration Predicts Neurological Outcomes

In OHCA survivors, longer elevated perfusion pressure duration with MAP >80 mmHg in the first 48 hours after ROSC was ...
Healio

Tissue perfusion pressure a potential target to guide clinical care of circulatory shock

Please provide your email address to receive an email when new articles are posted on . Tissue perfusion pressure may be a new target for BP optimization in circulatory shock. TPP was significantly ...

Bridge To Lifetm Secures FDA De Novo Clearance For Vitasmarttm Hypothermic Oxygenated Perfusion (HOPE) System, The First Device Cleared In The U.S. For Hypothermic Oxygenated ...

Bridge To Lifetm Secures FDA De Novo Clearance For Vitasmarttm Hypothermic Oxygenated Perfusion (HOPE) System, The First Device Cleared In The U.S. For Hypothermic Oxygenated Perfusion Of Donor Livers ...
Medindia

Bridge to Life™ Secures FDA De Novo Clearance for VitaSmart™ Hypothermic Oxygenated Perfusion (HOPE) System, the First Device Cleared in the U.S. for Hypothermic Oxygenated ...

The FDA clearance enables the commercial use of VitaSmart™ for hypothermic oxygenated perfusion of donor livers following static cold storage and prior to transplantation, provi ...